PathGroup

Personnel

Director: James Prescott, PhD, Lab Director
Phone: 888-474-5227
Email: mdx@pathgroup.com

Conditions and tests

127 conditions/phenotypes with 65 tests
Enter text to narrow down the list

4p partial monosomy syndrome1 test
5p partial monosomy syndrome1 test
Acquired polycythemia vera23 tests
Acute leukemia2 tests
Acute lymphoid leukemia27 tests
Acute myeloid leukemia23 tests
Aplastic anemia11 tests
Astrocytoma2 tests
Biliary tract neoplasm1 test
Breast adenocarcinoma1 test
Breast and colorectal cancer, susceptibility to1 test
Breast and/or ovarian cancer5 tests
Breast cancer, early-onset1 test
Breast cancer, familial male1 test
Breast cancer, susceptibility to1 test
Breast lobular carcinoma1 test
Breast neoplasm1 test
Carcinoma of colon7 tests
Carcinoma of pancreas8 tests
Celiac disease1 test
Chromosome 15q11.2 deletion syndrome1 test
Chromosome 1p36 deletion syndrome1 test
Chronic lymphatic leukemia7 tests
Chronic myelogenous leukemia, BCR-ABL1 positive18 tests
Colorectal / endometrial cancer4 tests
Colorectal cancer5 tests
Colorectal cancer, hereditary nonpolyposis, type 21 test
Colorectal cancer, susceptibility to, 121 test
Complete trisomy 13 syndrome1 test
Complete trisomy 21 syndrome1 test
Congenital plasminogen activator inhibitor type 1 deficiency6 tests
Deafness-lymphedema-leukemia syndrome11 tests
DiGeorge syndrome1 test
EGFR-related lung cancer3 tests
Endometrial carcinoma6 tests
Endometrial neoplasm2 tests
Erlotinib response3 tests
Esophageal carcinoma2 tests
Essential thrombocythemia22 tests
Ewing sarcoma1 test
Familial colorectal cancer4 tests
Familial prostate carcinoma1 test
Gastrointestinal stroma tumor2 tests
Gefitinib response3 tests
Germ cell tumor1 test
Glioma2 tests
Hairy cell leukemia7 tests
Hematologic disorder12 tests
Hematologic neoplasm13 tests
Hepatocellular carcinoma5 tests
Hereditary breast ovarian cancer syndrome1 test
Hereditary cancer-predisposing syndrome1 test
Hereditary diffuse gastric adenocarcinoma1 test
Hereditary nonpolyposis colon cancer1 test
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX111 tests
Homocystinuria due to methylene tetrahydrofolate reductase deficiency6 tests
Hypercoagulability6 tests
Juvenile myelomonocytic leukemia11 tests
Klinefelter syndrome1 test
Langerhans cell histiocytosis6 tests
Li-Fraumeni syndrome1 test
Li-Fraumeni syndrome 11 test
Lung carcinoma8 tests
Lymphoma2 tests
Lymphoma, non-Hodgkin, familial1 test
Lymphoproliferative disorder4 tests
Lymphoproliferative disorders, susceptibility to4 tests
Lynch syndrome6 tests
Lynch syndrome 11 test
Lynch syndrome 41 test
Lynch syndrome 51 test
Lynch syndrome 81 test
Malignant melanoma of skin1 test
Malignant tumor of kidney1 test
Malignant tumor of prostate1 test
Malignant tumor of thyroid gland8 tests
Malignant tumor of urinary bladder1 test
Mastocytosis1 test
Melanoma7 tests
Melanoma, cutaneous malignant, susceptibility to, 31 test
Monocytopenia with susceptibility to infections11 tests
MTHFR THERMOLABILE POLYMORPHISM6 tests
Myelodysplasia11 tests
Myelodysplastic syndrome32 tests
Myeloid leukemia11 tests
Myeloproliferative disorder29 tests
Myeloproliferative neoplasm34 tests
Neoplasm7 tests
Neoplasm of ovary1 test
Neoplasm of stomach1 test
Neoplasm of the genitourinary tract2 tests
Neoplasm of uterine cervix2 tests
Neoplasm of uterus2 tests
Non-Hodgkin lymphoma2 tests
Non-small cell lung carcinoma3 tests
Nonpapillary renal cell carcinoma1 test
Oligoastrocytoma2 tests
Oligodendroglioma2 tests
Ovarian cancer8 tests
Pancreatic cancer, susceptibility to, 11 test
Pancreatic cancer, susceptibility to, 21 test
Pancreatic cancer, susceptibility to, 41 test
Pregnancy loss, recurrent, susceptibility to, 22 tests
Primary myelofibrosis34 tests
Refractory anemia with ringed sideroblasts (clinical)29 tests
Renal cell carcinoma1 test
Renal hamartoma1 test
Salivary gland neoplasm1 test
Sarcoma1 test
Small cell lung carcinoma5 tests
Solid tumor7 tests
Squamous cell carcinoma5 tests
Squamous cell carcinoma of the head and neck4 tests
T-cell acute lymphoblastic leukemias2 tests
T-cell prolymphocytic leukemia2 tests
Thrombocythemia 134 tests
Thrombophilia due to activated protein C resistance7 tests
Thrombophilia due to factor V Leiden1 test
Thrombophilia due to thrombin defect6 tests
Thyroid cancer, nonmedullary, 16 tests
Thyroid gland carcinoma5 tests
Trisomy 181 test
Trisomy X syndrome1 test
Turner syndrome1 test
Tyrosine kinase inhibitor response3 tests
Urinary bladder carcinoma1 test
Von Hippel-Lindau syndrome1 test

List of services

Clinical Testing/Confirmation of Mutations Identified Previously

List of certifications/licenses

Certifications

CLIAHelpCertification number assigned by the Clinical Laboratory Improvement Amendments (CLIA) program to the laboratory director. Minimal field for US labs offering clinical tests. Optional field for international labs or US labs performing research tests. If pending renewal or record has not been updated, the expiration date may be in the past., Number: 44D2062928, Expiration date: 2024-05-13
CAP, Number: 8743308, Expiration date: 2024-11-30

Licenses

CA - California Department of Public Health CDPH, Number: COS 00800522, Expiration date: 2023-07-30
PA - Pennsylvania Department of Health PADOH, Number: 35484, Expiration date: 2023-08-15
TN - Tennessee Department of Health TDOH, Number: 0000004255, Expiration date: 2023-01-31

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.